FibroGen
Discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs. Learn more
Launch date
Employees
Market cap
$43.0m
Enterprise valuation
$49m (Public information from Sep 2024)
Share price
$0.416 FGEN
San Francisco California (HQ)
Authorizing premium user...